tiprankstipranks
Xtacy Therapeutics Welcomes New Board Member
Company Announcements

Xtacy Therapeutics Welcomes New Board Member

Story Highlights

Xtacy Therapeutics (TSE:XTCY) has released an update.

Don't Miss our Black Friday Offers:

Xtacy Therapeutics Corp. has announced changes to its Board of Directors, with Vanni Barbon joining as a Director and the new Audit Chair, bringing a wealth of experience in banking and public markets. The company expressed gratitude to Ashleigh Vogstad for her service as she steps down, and CEO Meris Kott anticipates continued advice from her. Xtacy Therapeutics focuses on wellness consumer products, including psychedelics and healthcare-related targets.

For further insights into TSE:XTCY stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskXtacy Therapeutics Rebrands to Pegasus Mercantile
TipRanks Canadian Auto-Generated NewsdeskXtacy Therapeutics Rebrands to Pegasus Mercantile
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App